Inspiration

INSPIRE MEDICAL SYSTEMS, INC. (NYSE: INSP) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Inspire Medical Systems, Inc.

Retrieved on: 
Tuesday, February 6, 2024
Obstructive sleep apnea, Action Replay, News, Patient, Inspiration, OSA, District court, Food, Sleep apnea, Advertising, Complaint, Court, Security (finance)

If you purchased or acquired Inspire Medical common stock, and/or would like to discuss your legal rights and options please visit Inspire Medical Systems, Inc.

Key Points: 
  • If you purchased or acquired Inspire Medical common stock, and/or would like to discuss your legal rights and options please visit Inspire Medical Systems, Inc.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
  • If you purchased or acquired Inspire Medical common stock, and/or would like to discuss your legal rights and options please visit Inspire Medical Systems, Inc.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Inspire Medical Systems, Inc. (INSP)

Retrieved on: 
Monday, February 5, 2024
News, Inspiration, OSA, GPM, Defendant, Suite, Court, Tobacco

You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

Key Points: 
  • You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.
  • On this news, Inspire Medical’s stock price fell $31.79, or 19.8%, to close at $129.65 per share on November 8, 2023, thereby injuring investors.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • Glancy Prongay & Murray LLP, Los Angeles

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Inspire Medical Systems, Inc. - INSP

Retrieved on: 
Saturday, February 3, 2024
Pomerantz, Ext, News, Patient, Inspiration, Prior, Complaint, LLP, Court, Action Replay, Pharmaceutical industry

NEW YORK, Feb. 03, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (“Inspire Medical” or the “Company”) (NYSE: INSP).

Key Points: 
  • NEW YORK, Feb. 03, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (“Inspire Medical” or the “Company”) (NYSE: INSP).
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • The class action concerns whether Inspire Medical and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Fitbots and Inspire Software: Joining Forces to Redefine OKR Success With Performance Management

Retrieved on: 
Friday, February 2, 2024
Partnership, Bias, OKR, Software, Inspiration, Organization, Video game

"At Fitbots, we've always been committed to empowering organizations to unleash their full potential," said Vidya Santhanam, Founder at Fitbots.

Key Points: 
  • "At Fitbots, we've always been committed to empowering organizations to unleash their full potential," said Vidya Santhanam, Founder at Fitbots.
  • Under this partnership, Inspire Software will now serve as the primary source for new inquiries seeking a holistic performance management platform.
  • Fitbots' existing customers will be able to seamlessly transition to the Inspire platform, ensuring continuity and enhanced features for their performance management needs.
  • With Fitbots' strengths and our advanced AI-powered tools, we are redefining performance management, offering organizations an unparalleled solution to supercharge their people and performance."

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Inspire Medical Systems, Inc. (INSP)

Retrieved on: 
Monday, January 29, 2024
Court, Suite, OSA, Inspiration, GPM, News, Defendant, Tobacco

You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

Key Points: 
  • You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.
  • On this news, Inspire Medical’s stock price fell $31.79, or 19.8%, to close at $129.65 per share on November 8, 2023, thereby injuring investors.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • Glancy Prongay & Murray LLP, Los Angeles

INSPIRE MEDICAL SYSTEMS, INC. (NYSE: INSP) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Inspire Medical Systems, Inc.

Retrieved on: 
Monday, January 29, 2024
Action Replay, Patient, Obstructive sleep apnea, Sleep apnea, Complaint, District court, Court, Advertising, Food, OSA, Inspiration, News, Tobacco

If you purchased or acquired Inspire Medical common stock, and/or would like to discuss your legal rights and options please visit Inspire Medical Systems, Inc.

Key Points: 
  • If you purchased or acquired Inspire Medical common stock, and/or would like to discuss your legal rights and options please visit Inspire Medical Systems, Inc.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
  • If you purchased or acquired Inspire Medical common stock, and/or would like to discuss your legal rights and options please visit Inspire Medical Systems, Inc.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Inspire Medical Systems, Inc. - INSP

Retrieved on: 
Friday, January 26, 2024
Pomerantz, Patient, LLP, Prior, Ext, Complaint, Court, Inspiration, Action Replay, News, Pharmaceutical industry

NEW YORK, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (“Inspire Medical” or the “Company”) (NYSE: INSP).

Key Points: 
  • NEW YORK, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (“Inspire Medical” or the “Company”) (NYSE: INSP).
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • The class action concerns whether Inspire Medical and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Inspire Medical Systems, Inc. Announces Jerry C. Griffin, M.D. to Retire from its Board after Sixteen Years of Service

Retrieved on: 
Friday, January 26, 2024
Patient, Intuitive Surgical, Obstructive sleep apnea, Partnership, Shareholder, OSA, Inspiration, Retirement, Management

“After sixteen years of service, we announce the retirement of Dr. Griffin from our Board of Directors.

Key Points: 
  • “After sixteen years of service, we announce the retirement of Dr. Griffin from our Board of Directors.
  • His contributions to our Board and organization are innumerable and we are grateful for the dedication and direction he provided to our organization,” said Tim Herbert, President and Chief Executive Officer of Inspire Medical Systems.
  • In December 2023, the Inspire Board appointed another esteemed physician and seasoned medical device executive with the appointment of Myriam J. Curet, M.D.
  • Dr. Curet currently serves as Executive Vice President and Chief Medical Officer of Intuitive Surgical.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Inspire Medical Systems, Inc. (INSP)

Retrieved on: 
Tuesday, January 23, 2024
Court, Suite, OSA, Inspiration, GPM, News, Defendant, Tobacco

You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

Key Points: 
  • You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.
  • On this news, Inspire Medical’s stock price fell $31.79, or 19.8%, to close at $129.65 per share on November 8, 2023, thereby injuring investors.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • Glancy Prongay & Murray LLP, Los Angeles

INSPIRE MEDICAL SYSTEMS, INC. (NYSE: INSP) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Inspire Medical Systems, Inc.

Retrieved on: 
Monday, January 22, 2024
Action Replay, Patient, Obstructive sleep apnea, Sleep apnea, Complaint, District court, Court, Advertising, Food, OSA, Inspiration, News, Tobacco

If you purchased or acquired Inspire Medical common stock, and/or would like to discuss your legal rights and options please visit Inspire Medical Systems, Inc.

Key Points: 
  • If you purchased or acquired Inspire Medical common stock, and/or would like to discuss your legal rights and options please visit Inspire Medical Systems, Inc.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
  • If you purchased or acquired Inspire Medical common stock, and/or would like to discuss your legal rights and options please visit Inspire Medical Systems, Inc.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.